MabQuest Therapeutics S.A.
- Address
- Avenue D'Ouchy 4
Sponsor Overview
Specializations
Advanced solid tumours
MabQuest Therapeutics S.A. focuses on advanced cancer histologies in which immune checkpoint blockade is an established treatment option, with interest spanning tumour types such as metastatic melanoma, lung cancer, renal cell carcinoma, hepatocellular carcinoma, and gastric cancer.
- Metastatic melanoma
- Lung cancer
- Renal cell carcinoma
- Hepatocellular carcinoma
- Gastric cancer
The clinical programme also includes tumour settings defined by microsatellite instability-high status, reflecting interest in immunologically responsive cancers.
Hematologic malignancies
The sponsor’s research scope extends to Hodgkin’s lymphoma, indicating involvement in cancer biology with relevance to lymphoid malignancies and immune-mediated treatment pathways.
- Hodgkin’s lymphoma
- Lymphoid malignancies
- Immune-mediated oncology
This area aligns with a therapeutic interest in cancers where immuno-oncology remains central to treatment development.
Immuno-oncology therapeutics
MabQuest Therapeutics S.A. is active in the development of therapies for advanced cancers using an immunotherapy-focused approach, including evaluation of a candidate studied as both monotherapy and in combination therapy settings.
- Monotherapy
- Combination therapy
- Immune checkpoint blockade
Its research interests centre on malignancies where immune-based treatment strategies are clinically relevant.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of MAQ-001 Monotherapy and Combination Therapy in Advanced Cancers with Approved Immune Checkpoint Blockade Options |  France | Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 4 sites across their trial portfolio.
Therapeutic Focus
- 1.Pathological Conditions, Signs and Symptoms1 trial91 other sponsors
Partnered Research Centres
4 centres- Address
- Avenue La Bataille Flandre Dunkerque, Cs 44229, 35042 Rennes
- Address
- 28 Rue Laennec, 69008 Lyon
- Address
- 114 Rue Edouard Vaillant, 94805 Villejuif
- Address
- 1 Avenue Irene Joliot Curie, 31059 Toulouse
Want to get in touch with this sponsor?
Send a question and we'll pass it on to MabQuest Therapeutics S.A..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.